High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q4
FY2027Q1
FY2027Q2
1.51B
-2.41%
0.036
+67.29%
1.49B
+0.06%
0.028
+42.94%
1.50B
+0.7%
0.094
+30.78%
Estimates Revision
The market is revising No Change the revenue expectations for Petco Health and Wellness Company, Inc. (WOOF) for FY2026, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -16.62%.
Revenue Estimates for FY2026
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2026
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-16.62%
In Past 3 Month
10 Analyst Rating
Wall Street analysts forecast WOOF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WOOF is 4.03 USD with a low forecast of 2.75 USD and a high forecast of 5.14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
7 Hold
1 Sell
Hold
Current: 3.060
Low
2.75
Averages
4.03
High
5.14
Current: 3.060
Low
2.75
Averages
4.03
High
5.14
Goldman Sachs
Buy
maintain
2025-12-02
New
Reason
Goldman Sachs
Price Target
2025-12-02
New
maintain
Buy
Reason
Goldman Sachs lowered the firm's price target on Petco to $4.53 from $5.14 and keeps a Buy rating on the shares. Petco reported an earnings beat for Q3 and plans to drive top-line growth in 2026 amid the competitive environment, the analyst tells investors in a research note. The services business is seen as a key differentiator, with ongoing efforts to improve utilization through staffing and marketing, and to enhance accessibility via technology and data sharing, Goldman says.
Morgan Stanley
Equal Weight
downgrade
2025-11-26
Reason
Morgan Stanley
Price Target
2025-11-26
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Petco to $3.75 from $4.50 and keeps an Equal Weight rating on the shares. Competitive dynamics and a weak macro picture add pressure, limiting visibility on the path to a sustained topline inflection and further profitability improvements, the analyst tells investors following the company's Q3 report.
BofA
Kendall Toscano
Underperform
maintain
$3
2025-11-26
Reason
BofA
Kendall Toscano
Price Target
$3
2025-11-26
maintain
Underperform
Reason
BofA analyst Kendall Toscano raised the firm's price target on Petco to $3 from $2.75 and keeps an Underperform rating on the shares. The firm raised its FY26 adjusted EBITDA and adjusted EPS estimates to reflect Q3 upside, but sees continued same-store sales/traffic softness in the near-term as well as longer-term risk that market share erosion could continue, the analyst tells investors.
Wells Fargo
Zachary Fadem
Equal Weight
maintain
$4
2025-08-29
Reason
Wells Fargo
Zachary Fadem
Price Target
$4
2025-08-29
maintain
Equal Weight
Reason
Wells Fargo analyst Zachary Fadem raised the firm's price target on Petco to $4 from $3.50 and keeps an Equal Weight rating on the shares. While Q2 comps were in-line, the firm sees Petco shares sharply higher tomorrow via EBITDA upside and additional signs of turnaround progress. That said, with topline still muted and high category competition, Wells stays sidelined.
UBS
Michael Lasser
Neutral
maintain
2025-08-29
Reason
UBS
Michael Lasser
Price Target
2025-08-29
maintain
Neutral
Reason
UBS analyst Michael Lasser raised the firm's price target on Petco to $3.70 from $3.25 and keeps a Neutral rating on the shares. The company's Q2 report showed ongoing margin improvement, which brought some optimism to the stock, the analyst tells investors in a research note. However, UBS believes Petco needs an improved market share trajectory to drive the shares higher.
Baird
Peter Benedict
Neutral
maintain
$4
2025-08-29
Reason
Baird
Peter Benedict
Price Target
$4
2025-08-29
maintain
Neutral
Reason
Baird analyst Peter Benedict raised the firm's price target on Petco to $4 from $3.50 and keeps a Neutral rating on the shares. The firm updated its model following beat and raise Q2 results with the company set up for a return to growth.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Petco Health and Wellness Company Inc (WOOF.O) is 14.54, compared to its 5-year average forward P/E of 56.26. For a more detailed relative valuation and DCF analysis to assess Petco Health and Wellness Company Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
56.26
Current PE
14.54
Overvalued PE
149.65
Undervalued PE
-37.12
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
11.83
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
14.54
Undervalued EV/EBITDA
9.13
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.47
Current PS
0.00
Overvalued PS
0.83
Undervalued PS
0.11
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
WOOF News & Events
Events Timeline
(ET)
2025-11-25
16:09:05
Petco projects FY25 capital expenditures between $125 million and $130 million.
2025-11-25
16:08:25
Petco projects a 2.5%-2.8% decline in FY25 revenue
2025-11-25
16:07:36
Petco reports a slight year-over-year decline in Q4 revenue.
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/a85f1c36ac30e4da199b401a15e165da9daa6e342fb94c3cb44412b230f543e5.jpg)
Preview
8.0
11-27NASDAQ.COMSignificant Wednesday Options Trading: NOW, WOOF, PD
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/4ded58ca806db3c9ac8cb944d7e172140f0231d05b9b63ec9a5de6f546dec388.png)
Preview
9.5
11-27BenzingaPetco (WOOF) Shares Surge 15%: What’s Behind the Rise?
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/17d0c54e6f46d5e30c61fba5f6024951db4d7cf37f5f9351f36737900902280b.png)
Preview
4.5
11-27BenzingaGold Rises More Than 1%; Nutanix Stock Declines Following Q1 Earnings Report
Sign Up For More News
People Also Watch
FAQ
What is Petco Health and Wellness Company Inc (WOOF) stock price today?
What is Petco Health and Wellness Company Inc (WOOF)'s business?
What is the price predicton of WOOF Stock?
What is Petco Health and Wellness Company Inc (WOOF)'s revenue for the last quarter?
What is Petco Health and Wellness Company Inc (WOOF)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Petco Health and Wellness Company Inc (WOOF)'s fundamentals?
How many employees does Petco Health and Wellness Company Inc (WOOF). have?